N30 Pharmaceuticals has selected Greenphire's global payment technology platforms, eClinicalGPS and ClinCard, to streamline payments to investigators and subjects throughout its Phase 1a/2b Cystic Fibrosis study commenced in the month of ...
Greenphire has signed a deal to provide its ClinCard technology platform to an undisclosed pharmaceutical company conducting a long-term clinical trial. Around 1,000 patients from six countries will participate in the five-year Phase III ...